Three Affiliates of Huons Group Honored with Export Tower Awards on Trade Day

- Achieving 7 Million Dollars in Exports for Huons BioPharma, 5 Million for Huons N and 3 Million Dollars for PanGen Biotech -

- Huons BioPharma’s CEO Kim Yeong-mok received a Minister of Trade, Industry and Energy Award for contributions to exports -

Huons Group was recognized for its strong performance in expanding overseas markets and increasing exports, as three of its affiliates were honored at the 62nd Trade Day ceremony.

Huons Group has announced on December 8 that at the event, Huons BioPharma (CEO, Dr. Kim Yeong-mok) received the 7 Million Dollar Export Tower, while Huons N (CEO Son Dong-Chul) and PanGen Biotech (CEO, Dr. Jaeseung Yoon) were awarded the 5 Million Dollar and 3 Million Dollar Export Towers, respectively.

The Trade Day ceremony, hosted by the Korea International Trade Association (KITA) and organized by the Ministry of Trade, Industry and Energy, is an annual event that commends companies for their contributions to developing global markets and driving export growth.

Huons BioPharma was recognized for its contribution to globalizing Korean pharmaceuticals by securing product registrations for its botulinum toxin ‘HUTOX^®‘ with health authorities in 15 countries, including Thailand, Iraq and Colombia, and achieving exports of approximately 9 million dollars (around 13.2 billion KRW) over the past year.

Huons N has been strengthening its presence in the global health and functional food market through Original Equipment Manufacturing (OEM) and Original Design Manufacturing (ODM) partnerships. Huons N has expanded exports to more than 14 countries across North America, Asia and Europe, leveraging differentiated competitive strengths such as proprietarily developed individually recognized functional food ingredients and unique dosage forms such as spout pouches.In addition, Huons N has recently acquired the health functional food manufacturer Biorosette to further enhance its core OEM and ODM capabilities and stably respond to rapidly increasing global export demand.

PanGen Biotech achieved exports of 3 million dollars with its erythropoietin (EPO) biosimilar products and received an Export Tower in recognition of this performance. The company currently exports its EPO pharmaceuticals to five countries, including Malaysia, Philippines, Saudi Arabia, Turkiye and Thailand, and plans to further expand into the Middle East and Africa while increasing overall sales.

In addition, Huons BioPharma’s CEO, Dr. Kim Yeong-mok received a commendation from the Minister of Trade, Industry and Energy as an exemplary export contributor, acknowledging his role in advancing Korea’s export performance.

CEO of Huons BioPharma, Dr. Kim Yeong-mok stated, "This award is regarded as the result of our strategic decision to establish an overseas sales division upon Huons BioPharma's founding in 2021, enabling sustained efforts in developing global markets. Moving forward, we remain committed to maintaining our strong export growth momentum, enhancing our competitive edge in the global market, and further solidifying our position as a leading player in the healthcare industry.”